Intestinal Inflammation and Colorectal Cancer

Epidemiology of the villain.- Colorectal cancer in patients with inflammatory bowel disease: influence of nutritional habits and environmental clues.- Inflammatory bowel disease high-risk groups.- Not all colorectal cancers are the same.- Getting familiar with familial colon cancer.- The adenomatous polyposis coli tumour-suppressor protein in normal gut tissue maintenance and cancer.- Mismatch repair competency predicts 5-fluorouracil effectiveness on patient survival.- Inflammatory bowel disease-related cancer — just the same as sporadic? — Pro.- Differences between sporadic and colitis-associated colorectal cancer.- Screening and surveillance.- Endoscopic guidelines for hereditary non-polyposis colorectal cancer, familial adenomatous polyposis, inflammatory bowel disease and sporadic colorectal cancer.- Which new techniques will replace classical surveillance?.- How to deal with dysplasia and adenomatous polyps in inflammatory bowel disease.- Taking dysplasia to the molecular level.- Inflammation driven carcinogenesis: the players.- Cancer originating from bone marrow stem cells: can we extrapolate from gastritis to colitis?.- Translating laboratory findings into clinics: of mice and man.- How can we prevent?.- Inner and outer environment.- Can we prevent inflammatory bowel disease-related colorectal cancer with 5-aminosalicylic acid, azathioprine, or 6-mercaptopurine? The clinical evidence.- How can we prevent colorectal cancer with ursodeoxycholic acid?.- Molecular actions of 5-ASA — the magic bullet.- 5-Aminosalicylic acid and replication fidelity.- New mechanisms of action of 5-aminosalicylic acid: PPAR?: how it decreases inflammation and cancer.- Mesalazine and the prevention of colorectal cancer in inflammatory bowel disease.- Mesalazine and cell cycleprogression.- Chemopreventive role of mesalazine in inflammatory bowel disease-associated colorectal cancer: the role of DNA methylation.- Molecular actions of 5-aminosalicylic acid: the magic bullet on epidermal growth factor receptor signalling.- State-of-the-Art Lecture.- State-of-the-Art Lecture: Infection, inflammation and cancer — the future.- Progression of cancer through inflammatory mechanisms.- An integrating concept of malignant progression in colorectal cancer.- The balance between survival and apoptosis.- The tumour microenvironment regulates components of the fucose biosynthesis pathways in colorectal cancer cells.